SAN DIEGO--(BUSINESS WIRE)--Cytori Therapeutics, Inc. (NASDAQ:CYTX) (Frankfurt:XMPA) announces financial results for the quarter ended September 30, 2006 and reports progress in its development of adipose stem cells in cardiovascular disease and for use in reconstructive surgery.
